GlassScriptPhysician profile
Philip Ilaria
NPI 1235105081
$825.09
in general payments reported to CMS, 2019-2025
22 companies · none reported in 2025
See the full distribution for Neurology (Psychiatry & Neurology)
Payments by year
General payments by program year, as reported to CMS.
General payments by year: 2019: $390 · 2020: $362 · 2021: $72.91.
Who reported paying
General payments only, as reported to CMS. Product names cover 2023-2025.
| Company | General payments | Years | Top products |
|---|---|---|---|
| Novartis Pharmaceuticals Corporation | $237.74 | 2019-2021 | |
| Ucb, INC. | $66.24 | 2019-2020 | |
| Biogen, INC. | $64.27 | 2019-2020 | |
| Emd Serono, INC. | $55.99 | 2019-2020 | |
| Allergan, INC. | $40.86 | 2020 | |
| Alexion Pharmaceuticals, INC. | $36.85 | 2019-2021 | |
| Amgen INC. | $34.52 | 2019 | |
| Lilly USA, LLC | $28.10 | 2019 | |
| Teva Pharmaceuticals USA, INC. | $27.61 | 2019-2020 | |
| Kyowa Kirin, INC. | $26.96 | 2020 | |
| Supernus Pharmaceuticals, INC. | $26.84 | 2019-2020 | |
| Mallinckrodt Hospital Products INC. | $26.63 | 2020 | |
| Genentech USA, INC. | $22.77 | 2019 | |
| Acadia Pharmaceuticals INC | $22.64 | 2019 | |
| Sunovion Pharmaceuticals INC. | $19.68 | 2020 |
Show all 22 companies
| Company | General payments | Years | Top products |
|---|---|---|---|
| Vertical Pharmaceuticals, LLC | $13.79 | 2020 | |
| Sk Life Science, INC. | $13.52 | 2021 | |
| E.R. Squibb & Sons, L.L.C. | $12.61 | 2020 | |
| Mdd US Operations, LLC | $12.54 | 2020 | |
| Grifols USA, LLC | $11.95 | 2020 | |
| Mallinckrodt Enterprises LLC | $11.77 | 2019 | |
| Acorda Therapeutics, INC | $11.21 | 2019 |
If you want to bring it up
Most clinicians are glad to talk about this. A respectful way in:
- "I saw Philip Ilaria listed in the CMS Open Payments database. Can you tell me about your work with those companies?"
- "Is there a generic or alternative to this medication, and would it work as well for me?"
- "What made you choose this particular treatment for my situation?"
These are normal questions. A good clinician will welcome them.
Share this page
Keep an eye on this page
Get an email when the next June refresh changes this page. No account needed.
Source: CMS Open Payments, program years 2019-2025, as reported to CMS by drug and device makers (published June 30, 2026). Drug and device detail covers 2023-2025.